- Home
- ZBAI vs ZTEK Comparison
ZBAI vs ZTEK Comparison
Compare ZBAI & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZBAI | ZTEK |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | Canada |
| Employees | 6 | N/A |
| Industry | Professional Services | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.1M | 68.8M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | ZBAI | ZTEK |
|---|---|---|
| Price | $7.54 | $0.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.9K | ★ 79.6K |
| Earning Date | 06-05-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.30 | $0.46 |
| 52 Week High | $11.94 | $1.84 |
Technical Indicators
Market Signals| Indicator | ZBAI | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 58.48 | 36.74 |
| Support Level | $5.86 | N/A |
| Resistance Level | $9.56 | $0.57 |
| Average True Range (ATR) | 0.75 | 0.04 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 72.57 | 34.32 |
Price Performance
Historical ComparisonAbout ZBAI ATIF Holdings Limited Ordinary Shares
ATIF Holdings Ltd is a consulting company. It provides financial consulting services to small and medium-sized enterprises. It operates in one operating segment, which is the consulting service business. The company prominently generated revenues from consulting services to its clients. Geographically, the maximum revenue is derived from Hong Kong.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.